XM does not provide services to residents of the United States of America.

Philip Morris suspends nationwide sales on Zyn.com after D.C. subpoena



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Philip Morris suspends nationwide sales on Zyn.com after D.C. subpoena</title></head><body>

June 17 (Reuters) -Tobacco giant Philip Morris International PM.N said on Monday that it would suspend online sales on Swedish Match North America's ZYN.com nationwide as the Zyn nicotine pouch maker responds to a subpoena from the District of Columbia (D.C.).

Philip Morris bought Swedish Match in a $16 billion deal in 2022 as the company looked to reduce its reliance on cigarettes amid stricter regulations, and a consumer shift towards alternatives to tobacco and traditional cigarettes.

The company said that Swedish Match North America had received a subpoena from D.C.'s Attorney General requesting information about its compliance with D.C.'s 2022 ban on the sale of all flavored tobacco.

In October 2022, D.C. banned the sale of all flavored tobacco, including flavored synthetic nicotine products.

Philip Morris said that it intends to comply with D.C.'s request and that in the event of an unfavorable outcome related to this matter, a material liability is reasonably possible.

The company said its preliminary investigation indicates that there have been sales of flavored nicotine pouch products in D.C., predominantly related to certain online sales platforms and some independent retailers.

"Swedish Match is conducting a full review of its sales and supply chain arrangements in D.C. and other U.S. localities where flavor bans may apply and is temporarily suspending all sales on ZYN.com until that assessment is complete," a Philip Morris spokesperson told Reuters.

Philip Morris has benefited from strong demand for its Zyn nicotine pouches in the U.S., which the company says do not contain tobacco.

In its first quarter results, reported in April, shipments of Zyn nicotine pouches grew nearly 80% compared with a year ago. However, sales on ZYN.com represent a "very small percentage of nationwide Zyn volumes," the company added on Monday.



Reporting by Juveria Tabassum; Editing by Alan Barona

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.